RESUMO
Despite the great potential of solid oxide electrochemical cells (SOCs) as highly efficient energy conversion devices, the undesirable high operating temperature limits their wider applicability. Herein, a novel approach to developing high-performance low-temperature SOCs (LT-SOCs) is presented through the use of an Er, Y, and Zr triple-doped bismuth oxide (EYZB). This study demonstrates that EYZB exhibits > 147 times higher ionic conductivity of 0.44 S cm-1 at 600 °C compared to commercial Y-stabilized zirconia electrolyte with excellent stability over 1000 h. By rationally incorporating EYZB in composite electrodes and bilayer electrolytes, the zirconia-based electrolyte LT-SOC achieves the unprecedentedly high performance of 3.45 and 2.02 W cm-2 in the fuel cell mode and 2.08 and 0.95 A cm-2 in the electrolysis cell mode at 700 °C and 600 °C, respectively. Further, a distinctive microstructural feature of EYZB that largely extends triple phase boundary at the interface is revealed through digital twinning. This work provides insights for developing high-performance LT-SOCs.
RESUMO
RATIONALE: The occurrence of bleeding and hematoma from bone metastasis of hepatocellular carcinoma (HCC) is extremely rare. PATIENT CONCERNS: We present a case of scapular metastasis of HCC in a 69-year-old man who presented with acute bleeding and hematoma. DIAGNOSES: Chest computed tomography showed a large hematoma within the right pectoral muscle of the right upper chest and an exophytic metastatic mass in the right scapula with bony destruction, which caused the intramuscular hematoma. The final diagnosis was scapular metastasis of HCC presenting as acute bleeding and hematoma. INTERVENTIONS: Selective right subclavian angiography showed a hypervascular metastatic lesion in the right scapula. Subsequently, embolization of the tumoral feeding artery using a microcoil was performed and tumoral bleeding was stopped. OUTCOMES: The patient was discharged on hospital day 14 without any complications. LESSONS: Despite being extremely rare, the possibility of bleeding from bone metastasis of HCC needs to be considered. Transcatheter arterial embolization may be an effective means to treat bleeding from bone metastasis of HCC.